CF PharmTech, Inc.
Status: Publicly traded
Direct answer
CF PharmTech, Inc. is publicly traded on HKSE under the ticker 2652.HK.
CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and...
Can you invest in CF PharmTech, Inc.?
Yes. CF PharmTech, Inc. is publicly traded on HKSE under the ticker 2652.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CF PharmTech, Inc.
Detailed equity research is provided by MarketSnap.